Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-173022.2CALL0 298.84TRUE00
2024-05-17350CALL0 085.49TRUE00
2024-05-174016.94CALL0 190.48TRUE00
2024-05-17450CALL0 086.55TRUE00
2024-05-17505.18CALL0 1277.79FALSE00
2024-05-17551.9CALL15 8677.87FALSE-1.64-0.46
2024-05-17601.27CALL9 25985.29FALSE-0.74-0.37
2024-05-17651.05CALL0 30981.2FALSE00
2024-05-17700.45CALL0 1581.91FALSE00
2024-05-17750.05CALL15 4469.65FALSE0.050
2024-05-17800CALL0 00FALSE00
2024-05-17850.55CALL0 60FALSE00
2024-05-17900.51CALL0 30FALSE00
2024-05-17300PUT0 00FALSE00
2024-05-17350PUT0 083.1FALSE00
2024-05-17401.19PUT2 2581.94FALSE1.190
2024-05-17452.74PUT1012 33579.62FALSE1.30.9
2024-05-17504.6PUT105 37766.22TRUE1.50.48
2024-05-17557.9PUT1 1475.36TRUE7.90
2024-05-176011.2PUT2 773.18TRUE1.740.18
2024-05-17650PUT0 074.15TRUE00
2024-05-17700PUT0 0114.73TRUE00
2024-05-17750PUT0 093.02TRUE00
2024-05-17800PUT0 0125.82TRUE00
2024-05-17850PUT0 0136.65TRUE00
2024-05-17900PUT0 0162.88TRUE00
2024-06-21100CALL0 0294.72TRUE00
2024-06-2112.50CALL0 0227.75TRUE00
2024-06-211533.04CALL0 0212.8TRUE00
2024-06-2117.512.6CALL0 1188.56TRUE00
2024-06-212050.1CALL0 3163.14TRUE00
2024-06-2122.523.9CALL0 0145.44TRUE00
2024-06-212539.2CALL0 7133.3TRUE00
2024-06-213026CALL0 60597.08TRUE00
2024-06-213528.62CALL0 12483.46TRUE00
2024-06-214012CALL40 22578.17TRUE120
2024-06-21458.6CALL45 8468.67TRUE8.60
2024-06-21506.1CALL0 18572.89FALSE00
2024-06-21554.2CALL0 28065.27FALSE00
2024-06-21601.89CALL71 26366.47FALSE-0.91-0.33
2024-06-21653.3CALL0 190764.38FALSE00
2024-06-21700.9CALL1 117664.6FALSE0.90
2024-06-21750.45CALL5 9267.65FALSE-0.25-0.36
2024-06-21801.25CALL0 440FALSE00
2024-06-21850.35CALL0 1190FALSE00
2024-06-21900.65CALL0 690FALSE00
2024-06-21950.45CALL0 510FALSE00
2024-06-211002CALL0 790FALSE00
2024-06-211052.65CALL0 310FALSE00
2024-06-211101.01CALL0 104132.29FALSE00
2024-06-211150.9CALL0 130FALSE00
2024-06-211201.5CALL0 60FALSE00
2024-06-211250.83CALL0 40FALSE00
2024-06-211300.7CALL0 610FALSE00
2024-06-211350.19CALL0 2850FALSE00
2024-06-21100PUT0 00FALSE00
2024-06-2112.50.1PUT0 50FALSE00
2024-06-21152.5PUT0 00FALSE00
2024-06-2117.50.5PUT0 120FALSE00
2024-06-21200.37PUT0 160FALSE00
2024-06-2122.50.9PUT0 00FALSE00
2024-06-21250.3PUT0 5480FALSE00
2024-06-21300.5PUT0 23108.07FALSE00
2024-06-21350.6PUT0 18071.37FALSE00
2024-06-21401.34PUT0 10769.33FALSE00
2024-06-21452.85PUT2 20173.2FALSE0.40.16
2024-06-21505.5PUT31 95257.44TRUE1.330.32
2024-06-21558.1PUT34 23364.6TRUE0.920.13
2024-06-21607.91PUT0 105162.22TRUE00
2024-06-216514.23PUT0 38855.8TRUE00
2024-06-217014.8PUT0 6667.08TRUE00
2024-06-217515.3PUT0 4775.99TRUE00
2024-06-218024.31PUT0 8780.56TRUE00
2024-06-218520.2PUT0 13105.45TRUE00
2024-06-219033PUT0 107983.05TRUE00
2024-06-219535.8PUT0 0101.1TRUE00
2024-06-2110038.5PUT0 0114.69TRUE00
2024-06-211050PUT0 0132.24TRUE00
2024-06-211100PUT0 0137.96TRUE00
2024-06-211150PUT0 0123.23TRUE00
2024-06-211200PUT0 0153.7TRUE00
2024-06-211250PUT0 0147.62TRUE00
2024-06-211300PUT0 0141.59TRUE00
2024-06-2113586.3PUT0 0159.69TRUE00
2024-07-19250CALL0 064.37TRUE00
2024-07-19300CALL0 083.6TRUE00
2024-07-19350CALL0 074.15TRUE00
2024-07-19400CALL0 066.47TRUE00
2024-07-194513.4CALL0 2365.75TRUE00
2024-07-195018.65CALL0 263.07FALSE00
2024-07-19554.6CALL1 3863.19FALSE-0.8-0.15
2024-07-19602.59CALL6 12463.37FALSE2.590
2024-07-19651.65CALL10 9562.2FALSE-1-0.38
2024-07-19703.58CALL0 2465.03FALSE00
2024-07-19751.3CALL0 207261.02FALSE00
2024-07-19800.8CALL0 962.81FALSE00
2024-07-19852.65CALL0 463.45FALSE00
2024-07-19904.5CALL0 600FALSE00
2024-07-19951.65CALL0 6790FALSE00
2024-07-191000.4CALL0 4000FALSE00
2024-07-191050.44CALL0 310FALSE00
2024-07-19250PUT0 00FALSE00
2024-07-19302.33PUT0 169.73FALSE00
2024-07-19352.32PUT0 475.91FALSE00
2024-07-19401.15PUT0 1669.63FALSE00
2024-07-19452.65PUT0 6164.68FALSE00
2024-07-19504.75PUT0 5361.95TRUE00
2024-07-19557.93PUT0 208261.75TRUE00
2024-07-19609.9PUT0 12361.32TRUE00
2024-07-196513PUT0 9662.23TRUE00
2024-07-197013.5PUT0 257.28TRUE00
2024-07-197521PUT0 660.25TRUE00
2024-07-198018.8PUT0 673.24TRUE00
2024-07-198530.67PUT0 186.93TRUE00
2024-07-19900PUT0 097.34TRUE00
2024-07-19950PUT0 0107.16TRUE00
2024-07-191000PUT0 0102.13TRUE00
2024-07-191050PUT0 0118.09TRUE00
2024-10-183021.42CALL4 064.39TRUE21.420
2024-10-18350CALL0 069.3TRUE00
2024-10-18400CALL0 064.51TRUE00
2024-10-18450CALL0 065.13TRUE00
2024-10-185010.2CALL0 663.25FALSE00
2024-10-185512.3CALL0 561.39FALSE00
2024-10-18609.1CALL0 560.15FALSE00
2024-10-18650CALL0 057.95FALSE00
2024-10-18703.7CALL0 106861.39FALSE00
2024-10-18752.75CALL0 1356.43FALSE00
2024-10-18803.52CALL0 253.2FALSE00
2024-10-18852.7CALL0 164.29FALSE00
2024-10-18900CALL0 063.75FALSE00
2024-10-18950CALL0 065.76FALSE00
2024-10-181000CALL0 068.1FALSE00
2024-10-181051.25CALL0 158.91FALSE00
2024-10-18300.8PUT0 366.77FALSE00
2024-10-18351.63PUT0 261.71FALSE00
2024-10-18402.45PUT0 1459.97FALSE00
2024-10-18455.1PUT0 3659.76FALSE00
2024-10-18507.6PUT30 2352.49TRUE7.60
2024-10-18558.29PUT0 659.7TRUE00
2024-10-186010.3PUT0 657.08TRUE00
2024-10-186513.2PUT0 2159.29TRUE00
2024-10-18700PUT0 059.42TRUE00
2024-10-18750PUT0 058.02TRUE00
2024-10-18800PUT0 059.39TRUE00
2024-10-18850PUT0 058.47TRUE00
2024-10-18900PUT0 065.33TRUE00
2024-10-18950PUT0 079.71TRUE00
2024-10-181000PUT0 086.69TRUE00
2024-10-181050PUT0 090.77TRUE00
2024-12-201053.2CALL0 1133.08TRUE00
2024-12-2012.551.1CALL0 1119.32TRUE00
2024-12-20150CALL0 0114.11TRUE00
2024-12-2017.514.67CALL0 396.92TRUE00
2024-12-202045CALL0 886.12TRUE00
2024-12-2022.538.3CALL0 381.93TRUE00
2024-12-202531CALL0 6664.1TRUE00
2024-12-203027.9CALL0 762.56TRUE00
2024-12-203534.8CALL0 2559.12TRUE00
2024-12-204017CALL0 858.78TRUE00
2024-12-204519.5CALL0 1859.7TRUE00
2024-12-205020.7CALL0 1659.56FALSE00
2024-12-20557.8CALL5 261.78FALSE7.80
2024-12-20607.45CALL0 110557.15FALSE00
2024-12-20656.05CALL0 46956.08FALSE00
2024-12-20705CALL0 131057.53FALSE00
2024-12-207511.6CALL0 11456FALSE00
2024-12-20804CALL0 173553.89FALSE00
2024-12-20854.5CALL0 79954.85FALSE00
2024-12-20903.5CALL0 24255.56FALSE00
2024-12-20951.6CALL0 20453.87FALSE00
2024-12-201004.4CALL0 355.75FALSE00
2024-12-201054CALL0 2455.26FALSE00
2024-12-201101.55CALL0 154.36FALSE00
2024-12-201151.2CALL0 156.08FALSE00
2024-12-201200CALL0 00FALSE00
2024-12-201250CALL0 00FALSE00
2024-12-201301.66CALL0 130FALSE00
2024-12-201350.64CALL0 390FALSE00
2024-12-20100.3PUT0 10FALSE00
2024-12-2012.51PUT0 10FALSE00
2024-12-20153.5PUT0 30FALSE00
2024-12-2017.52.07PUT0 50FALSE00
2024-12-20200.4PUT0 420FALSE00
2024-12-2022.51.22PUT0 360FALSE00
2024-12-20251.63PUT0 1976.58FALSE00
2024-12-20301.05PUT0 6063.9FALSE00
2024-12-20351.45PUT0 7955.88FALSE00
2024-12-20403.5PUT0 8260.96FALSE00
2024-12-20454.44PUT0 5357.23FALSE00
2024-12-20507.8PUT0 53859.91TRUE00
2024-12-20556PUT0 14557.23TRUE00
2024-12-206010.4PUT0 11959.38TRUE00
2024-12-206513.4PUT0 16457.16TRUE00
2024-12-20700PUT0 059.6TRUE00
2024-12-207516PUT0 1156.19TRUE00
2024-12-20800PUT0 056.6TRUE00
2024-12-208528.9PUT0 257.92TRUE00
2024-12-209054.2PUT0 2060.56TRUE00
2024-12-209562.6PUT0 674.31TRUE00
2024-12-201000PUT0 074.77TRUE00
2024-12-2010545.62PUT0 081.87TRUE00
2024-12-201100PUT0 081.85TRUE00
2024-12-201150PUT0 076.15TRUE00
2024-12-201200PUT0 085.34TRUE00
2024-12-201250PUT0 088.27TRUE00
2024-12-201300PUT0 093.96TRUE00
2024-12-201350PUT0 096.68TRUE00
2025-01-171052.45CALL0 0124.57TRUE00
2025-01-1712.531.5CALL0 2111.53TRUE00
2025-01-17150CALL0 097.6TRUE00
2025-01-1717.531.1CALL0 290.31TRUE00
2025-01-172046.11CALL0 18481.23TRUE00
2025-01-1722.548CALL0 14675.24TRUE00
2025-01-172539.5CALL0 8265.95TRUE00
2025-01-173029.8CALL0 15664.47TRUE00
2025-01-173519CALL10 7060.36TRUE190
2025-01-174021CALL0 8061.11TRUE00
2025-01-174516.97CALL0 1555.98TRUE00
2025-01-175024.5CALL0 59458.74FALSE00
2025-01-17559.67CALL0 12658.71FALSE00
2025-01-176010.46CALL0 13358.02FALSE00
2025-01-17655.3CALL6 39758.78FALSE5.30
2025-01-17705CALL0 19255.2FALSE00
2025-01-17754.1CALL0 119856.78FALSE00
2025-01-17803.35CALL0 12352.07FALSE00
2025-01-17854.7CALL0 13753.12FALSE00
2025-01-17902.25CALL0 13156.42FALSE00
2025-01-17953.8CALL0 33460.88FALSE00
2025-01-171001.05CALL1 5055.23FALSE1.050
2025-01-171055.1CALL0 1862.34FALSE00
2025-01-171102.7CALL0 255.33FALSE00
2025-01-171150.8CALL0 2665.59FALSE00
2025-01-171200CALL0 065.62FALSE00
2025-01-171251CALL0 1920FALSE00
2025-01-171300.75CALL0 1210FALSE00
2025-01-171350.6CALL0 3960FALSE00
2025-01-17100.3PUT0 90FALSE00
2025-01-1712.50.1PUT0 1090FALSE00
2025-01-17150PUT0 00FALSE00
2025-01-1717.52PUT0 150FALSE00
2025-01-17201PUT0 70FALSE00
2025-01-1722.51.23PUT0 80FALSE00
2025-01-17250.9PUT0 15764.63FALSE00
2025-01-17301.4PUT0 10359.26FALSE00
2025-01-17351.9PUT0 54060.69FALSE00
2025-01-17403.1PUT0 73660.85FALSE00
2025-01-17453.1PUT0 4657.05FALSE00
2025-01-17508.02PUT4 15058.58TRUE0.090.01
2025-01-17559.5PUT0 9856.7TRUE00
2025-01-176012.3PUT0 16155.44TRUE00
2025-01-176515.5PUT0 18456.98TRUE00
2025-01-177018.76PUT0 29158.47TRUE00
2025-01-177521.4PUT0 2556.84TRUE00
2025-01-178024.8PUT0 560.2TRUE00
2025-01-178528.78PUT0 760.36TRUE00
2025-01-179040.16PUT0 81353.13TRUE00
2025-01-179531.5PUT0 7075.56TRUE00
2025-01-1710041.97PUT0 477.46TRUE00
2025-01-1710555.9PUT0 079TRUE00
2025-01-1711054.9PUT0 2082.36TRUE00
2025-01-171150PUT0 082.15TRUE00
2025-01-1712064PUT0 47689.65TRUE00
2025-01-1712576.28PUT0 092.57TRUE00
2025-01-171300PUT0 089.41TRUE00
2025-01-1713587.75PUT0 095.83TRUE00
2026-01-16200CALL0 054.4TRUE00
2026-01-1622.537.3CALL0 168.74TRUE00
2026-01-162537.5CALL0 258.21TRUE00
2026-01-163037.5CALL0 255.55TRUE00
2026-01-163538CALL0 157.97TRUE00
2026-01-164021CALL0 657.66TRUE00
2026-01-164525.3CALL0 457.19TRUE00
2026-01-16500CALL0 055FALSE00
2026-01-165523.29CALL0 554.75FALSE00
2026-01-166024.6CALL0 3554.28FALSE00
2026-01-166524.2CALL0 3352.92FALSE00
2026-01-167012.9CALL0 37554.09FALSE00
2026-01-167512.52CALL0 7052.72FALSE00
2026-01-168011.26CALL0 12553.07FALSE00
2026-01-16859.53CALL0 24951.74FALSE00
2026-01-16908.95CALL0 8452.32FALSE00
2026-01-169513.8CALL0 1849.97FALSE00
2026-01-161007.29CALL0 2748.34FALSE00
2026-01-161056.5CALL0 10448.97FALSE00
2026-01-16200.6PUT0 9562.56FALSE00
2026-01-1622.51.2PUT0 1261.64FALSE00
2026-01-16251.25PUT0 2860.95FALSE00
2026-01-16302.25PUT0 7251.65FALSE00
2026-01-16353.4PUT0 6158.2FALSE00
2026-01-16406.36PUT0 5161.04FALSE00
2026-01-16456.9PUT0 3156.55FALSE00
2026-01-165011.8PUT0 106755.55TRUE00
2026-01-165512.8PUT0 74855.81TRUE00
2026-01-166011.55PUT0 1655.47TRUE00
2026-01-166518.55PUT0 1654.67TRUE00
2026-01-167019.5PUT0 8655.78TRUE00
2026-01-167521PUT0 1053.9TRUE00
2026-01-168024.6PUT0 2252.53TRUE00
2026-01-168528.3PUT0 7953.83TRUE00
2026-01-16900PUT0 053.74TRUE00
2026-01-16950PUT0 050TRUE00
2026-01-161000PUT0 059.33TRUE00
2026-01-161050PUT0 057.8TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm